Responsiveness and minimum important change of the Pharmacotherapeutic Symptom Evaluation-20-Australian version: a tool for measuring changes in medicine-related symptoms over time.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  International Journal of Clinical Pharmacy

• Publication date

  2025-11-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11096-025-02045-4PMID 41222603PMCID PMC12992458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancing provider adoption of patient-reported outcome measures (PROMs) through implementation science: insights from two international workshops

  2025cited by this paper
• Patient reported tools for assessing potential medicine-related symptoms: A systematic review.

  2025cited by this paper
• Tool for longitudinal monitoring of medicine‐related symptoms in older people: a feasibility study

  2025cited by this paper
• The association between continuous polypharmacy and hospitalization, emergency department visits, and death in older adults: a nationwide large cohort study

  2024cited by this paper
• Role of Genetic Testing in Diagnosis and Prognosis Prediction in Hypertrophic Cardiomyopathy in Korea

  2024cited by this paper
• Polypharmacy and Elevated Risk of Severe Adverse Events in Older Adults Based on the Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting System Database

  2024cited by this paper
• Patient-reported outcome measures for medication treatment satisfaction: a systematic review of measure development and measurement properties

  2024cited by this paper
• Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update

  2023cited by this paper
• Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.

  2022cited by this paper
• Pharmacist-led medication reviews in primary healthcare for adult community-dwelling patients – a descriptive study charting a new target group

  2022cited by this paper
• When symptoms become side effects: Development of the side effect attribution scale (SEAS).

  2020cited by this paper
• Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness

  2019cited by this paper
• Nurse-led medicines’ monitoring in care homes, implementing the Adverse Drug Reaction (ADRe) Profile improvement initiative for mental health medicines: An observational and interview study

  2019cited by this paper
• Understanding the Minimal Clinically Important Difference (MCID) of Patient-Reported Outcome Measures

  2019cited by this paper
• Effects of medication reviews on use of potentially inappropriate medications in elderly patients; a cross-sectional study in Swedish primary care

  2018cited by this paper
• Medication management in older adults

  2018cited by this paper
• Evaluation of Potentially Drug-Related Patient-Reported Common Symptoms Assessed During Clinical Medication Reviews: A Cross-Sectional Observational Study

  2017cited by this paper
• Medication reviews in primary care in Sweden: importance of clinical pharmacists’ recommendations on drug-related problems

  2016cited by this paper
• National Indicators for Quality of Drug Therapy in Older Persons: the Swedish Experience from the First 10 Years

  2015cited by this paper
• Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study

  2015cited by this paper
• Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study

  2014cited by this paper
• Minimal clinically important difference: defining what really matters to patients.

  2014cited by this paper
• Signs and symptoms indicative of potential adverse drug reactions in homecare patients.

  2013cited by this paper
• PHARMACOEPIDEMIOLOGYAND PRESCRIPTION Recognition of adverse drug events in older hospitalized medical patients

  2012cited by this paper
• Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients.

  2011cited by this paper
• Beyond the Prescription: Medication Monitoring and Adverse Drug Events in Older Adults

  2011cited by this paper
• The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes.

  2010cited by this paper
• Clinical Versus Statistical Significance: Interpreting P Values and Confidence Intervals Related to Measures of Association to Guide Decision Making

  2010cited by this paper
• The minimal detectable change should not replace the minimal important difference.

  2010cited by this paper
• The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study

  2010cited by this paper
• The minimal detectable change cannot reliably replace the minimal important difference.

  2010cited by this paper
• Linking measurement error to minimal important change of patient-reported outcomes.

  2009cited by this paper
• Global Rating of Change Scales: A Review of Strengths and Weaknesses and Considerations for Design

  2009cited by this paper
• Global Rating of Change scales.

  2009cited by this paper
• PHASE-20: Ett nytt instrument för skattning av möjliga läkemedelsrelaterade symtom hos äldre personer i äldreboende

  2009cited by this paper
• The use of questionnaires for measuring patient‐reported side effects of drugs: its importance and methodological challenges

  2008cited by this paper
• Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.

  2008cited by this paper
• Mix of methods is needed to identify adverse events in general practice: A prospective observational study

  2008cited by this paper
• Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands.

  2008cited by this paper
• Understanding diagnostic tests 3: receiver operating characteristic curves

  2007cited by this paper
• Quality criteria were proposed for measurement properties of health status questionnaires.

  2007cited by this paper
• Understanding the minimum clinically important difference: a review of concepts and methods.

  2007cited by this paper
• Symptom burden: multiple symptoms and their impact as patient-reported outcomes.

  2007cited by this paper
• Health and Quality of Life Outcomes

  2006cited by this paper
• Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach

  2006cited by this paper
• Reliability and validity of clinical outcome measurements of osteoarthritis of the hip and knee — A review of the literature

  2005cited by this paper
• Assessing the Minimally Clinically Significant Difference: Scientific Considerations, Challenges and Solutions

  2005cited by this paper
• Defining clinically meaningful change in health-related quality of life.

  2003cited by this paper
• A critical look at transition ratings.

  2002cited by this paper
• Evaluation of a patient event report monitoring system

  2000cited by this paper
• Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach.

  1997cited by this paper
• Interpretation of quality of life changes

  1993cited by this paper
• Measurement of health status. Ascertaining the minimal clinically important difference.

  1989cited by this paper

• No citing papers are available for this paper.